'West is honored to receive an INTERPHEX 2022 Exhibitor Award recognizing the innovation of our DeltaCube Modeling Platform,' said
The DeltaCube Modeling Platform, a secure online vial integrity software modeling platform designed to help developers make more confident decisions about their container closure systems (CCS), uses a big-data approach, built on 90-plus years of CCS and container closure integrity (CCI) experience. The DeltaCube modeling platform provides an efficient and cost-effective tool to guide vial, stopper and seal combination selection based on fit, and supports the troubleshooting of defects or CCI failures due to component dimensional issues.
For more information about INTERPHEX 2022 and the Exhibitor Award, please visit INTERPHEX's Exhibitor Awards website: www.interphex.com/en-us/exhibit/exhibitor-awards.html.
Forward-Looking Statements
Certain forward-looking statements are included in this press release. They use words such as 'ensure,' 'reduce,' 'accelerate,' and other similar terminology. These statements reflect management's current expectations regarding future events and operating performance and speak only as of the date of this release. There is no certainty that actual results will be achieved in-line with current expectations. Specifically, there is no certainty that the DeltaCube Modeling Platform will achieve any particular result. These forward-looking statements involve a number of risks and uncertainties. The following are some of the factors that could cause our actual results to differ materially from those expressed in or underlying our forward-looking statements: customer decisions to move forward with our new products and product categories; dependence on third-party suppliers and partners; and the ability to meet development milestones with key customers. These important factors are not all inclusive. For a description of certain additional factors that could cause West's future results to differ from those expressed in any such forward-looking statements, see Item 1A, entitled 'Risk Factors,' in West's Annual Report on Form 10-K for the year ended
About West
Headquartered in
All trademarks and registered trademarks used in this release are the property of
Contact:
Director
T: +1-484-983-4893
E: Cynthia.Salitsky@westpharma.com
Vice President
T: +1-610-594-3054
E: Michele.Polinsky@westpharma.com
(C) 2022 Electronic News Publishing, source